UC Health’s UC Gardner Neuroscience Institute is leading the way in implementing cutting-edge screening tools for Alzheimer’s disease and offering patients access to the latest therapies and treatments, including LECANEMAB, a disease-modifying treatment approved by the FDA in July 2023.